• [Shinhan Investment] EOFlow, Much-anticipated schedule taking shape

  • Mar.09, 2021 [EOFlow] Much-anticipated schedule taking shape.PDF (1,005,891k)
  • EOFlow is sharing full English version of our recent analyst report from Shinhan Investment Corp. published on March 9th. 
    It was written by two pharmaceutical/bio analysts DongGun Lee and JaeHee Won.
    Please refer to the attached file for the report and the article from Business Korea posted on March 10th. 

    -EOPatch’s debut in Korean market on March 29
    -EOPatch will be sold through the domestic partner Huons in online channel
    -EOFlow plans to ramp up sales to a European partner Menarini after obtaining the CE marking in May
    -with the schedule for EOPatch taking shape, related earnings momentum should pick up
    -Plans to expand into markets for wearable artificial pancreas/kidney and non-insulin drug delivery solutions

    Thank you for your interest and support, and we will always keep you posted!
    If you have further questions, please send an email to ir.pr@eoflow.com.


We use cookies. By continuing to use our site you accept our cookie policy. Find out more about our privacy policy here